Navigation Links
Palivizumab in Medical News

MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics

...e: Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis with palivizumab Among Preterm Infants After Valuing a Reduction in Persistent Wheezing (Pos...llance Data for Georgia and Implications for Prophylactic Administration of palivizumab (Poster #P32) Mark Eggleston, PharmD, MBA, Saturday, October 27th, 2007 fr...
Palivizumab in Biological Technology

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease

...but not currently recommended for prophylaxis under the AAP guidelines. -- Cost Implications of Expanding Risk Factors for RSV Prophylaxis with palivizumab for Infants 32-35 Weeks Gestation (Poster #29) - Leonard Krilov, MD, Friday, October 10, 2008 from 6:00 - 6:30 p.m. BACKGROUND: AAP Red Book ...

MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition

... -- Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis with palivizumab Among Preterm Infants After Valuing a Reduction in Persistent Wheezing ...ce Data for Georgia and Implications for Prophylactic Administration of palivizumab (Poster #P32) - Mark Eggleston, PharmD, MBA, Saturday, October 27th, 20...
Palivizumab in other areas

Palivizumab - Wikipedia, the free encyclopedia

Palivizumab is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of Respiratory Syncytial Virus (RSV) infections. It is recommended for certain infants that are high-risk, see below.

Palivizumab

Palivizumab is a humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology. ... An example of a preparation of palivizumab is Synagis® ...

Palivizumab Facts and Comparisons at Drugs.com

All about Palivizumab. View complete and up to date Palivizumab information - part of the Drugs.com trusted medication database.

Palivizumab Side Effects | Drugs.com

Comprehensive and accurate Palivizumab side effects information for consumers and healthcare professionals. ... side effects for Palivizumab may not be ...

Palivizumab: Information from Answers.com

Palivizumab Brand names: Synagis™ Español: Palivizumab , Solución para inyección Palivizumab Solution for injection What is this medicine?

Update on Palivizumab

: Respiratory syncytial virus (RSV) is one of the leading causes of severe respiratory illness in infants and young children.
Other Tags
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... ... August 04, 2015 , ... A new report by ... reseller channel will grow at least 6 percent in 2015, as solution providers ... greater than their OEM/vendor partners. , The 2112 Group’s 2015 Midyear Channel ...
(Date:8/4/2015)... ... August 04, 2015 , ... Driving skills ... end to driving, says the August 2015 Harvard Health Letter. , "Age and ... It requires an individual assessment of skills," says Lissa Kapust, a social worker ...
(Date:8/4/2015)... ... , ... Updated enrollment data on the top U.S. health plans, as collected ... http://www.AISHealth.com . The data is free to all registered users to AISHealth.com. Based ... on the website’s “Data” section include:, , Top 25 U.S. ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... The ... designed to treat Retinitis pigmentosa, a rare eye disease that progressively causes blindness, were ... Academy of Ophthalmology. According to the results of the trial, the implant, more commonly ...
Breaking Medicine News(10 mins):Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2
(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 /PRNewswire/ ... and services for gene function analysis and biomarker ... Guide RNA (sgRNA) Knockout Library targeting all human ... specifically and permanently "knock out" a gene,s function. ... provides a high throughput screening tool so that ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
Other Contents